Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 01, 2004 08:14 ET | Source: Crucell N.V.

Crucell's PER.C6(R)-Based Vaccine Protects Monkeys from Ebola

LEIDEN, Netherlands, June 1, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) has announced that a single dose of its vaccine has completely protected...
May 28, 2004 02:05 ET | Source: Crucell N.V.

Crucell Announces June 3 Webcast of Annual General Meeting of Shareholders

LEIDEN, The Netherlands, May 28, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) has announced that it will webcast its Annual General Meeting of...
May 10, 2004 02:10 ET | Source: Crucell N.V.

Jan Pieter Oosterveld and Domenico Valerio nominated to Crucell's Supervisory Board

LEIDEN, The Netherlands, May 10, 2004 (PRIMEZONE) -- Dutch vaccine and antibody company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today the nomination of Jan Pieter Oosterveld and Domenico...
April 14, 2004 02:27 ET | Source: Crucell N.V.

Crucell Announces First Quarter 2004 Results

LEIDEN, Netherlands, April 14, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced its financial results for the first quarter of 2004....
March 30, 2004 01:09 ET | Source: Crucell N.V.

Crucell Receives NIH Support for Candidate Malaria Vaccine Development

LEIDEN, The Netherlands, March 30, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that the National Institute of Allergy and Infectious...
March 24, 2004 08:14 ET | Source: Crucell N.V.

Aeras partners with Crucell to develop TB vaccine

LEIDEN, The Netherlands, March 24, 2004 (PRIMEZONE) -- Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and the Aeras Global TB Vaccine Foundation of Bethesda, Maryland, announced today a new collaboration...
March 16, 2004 02:13 ET | Source: Crucell N.V.

Crucell and NeoTropiX Enter PER.C6(TM) Licensing Agreement in Viral Therapy in Oncology

LEIDEN, The Netherlands and GAITHERSBURG, Md., March 16, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and U.S.-based NeoTropiX, Inc. today announced that...
March 16, 2004 02:05 ET | Source: Crucell N.V.

ML Laboratories Renews PER.C6(TM) License Agreement with Crucell

LEIDEN, The Netherlands, March 16, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that UK-based ML Laboratories has decided to renew its...
January 26, 2004 02:35 ET | Source: Crucell N.V.

Crucell Announces 2003 Annual Results

LEIDEN, The Netherlands, Jan. 26, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced its 2003 financial results. Crucell's revenues for the...
January 26, 2004 02:15 ET | Source: Crucell N.V.

Crucell Announces Nomination of Ronald Brus as CEO

LEIDEN, The Netherlands, Jan. 26, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced the nomination of a new Chief Executive Officer, Ronald...